Literature DB >> 19353393

The incidence of neuro-ophthalmic diseases in Singapore: a prospective study in public hospitals.

Su Ann Lim1, Wan Ling Wong, Esther Fu, Kong Yong Goh, Alvin Seah, Clement Tan, Sharon Tow, James F Cullen, Tien Y Wong.   

Abstract

PURPOSE: To describe the incidence of neuro-ophthalmic diseases in a multi-ethnic Asian population in Singapore.
METHODS: Prospective study in public hospitals in Singapore. All neuro-ophthalmic cases seen in four public sector hospitals over a 22-month period (September 2002 to June 2004) were identified using a standardized protocol. The 2004 Singapore population was used as a denominator to estimate annual incidence. The prevalence of ischemic risk factors (hypertension, diabetes, and hypercholesterolemia) among cases was compared to population data.
RESULTS: A total of 1,356 patients with neuro-ophthalmic diseases were seen during the study period, of which 627 were new incident cases. The overall annual incidence of neuro-ophthalmic diseases was 9.81 per 100,000 (95% confidence interval, 8.80-10.90). The incidence increased with age. After controlling for age, the annual incidence was similar between men (10.75 per 100,000) and women (9.00 per 100,000), but was higher in Chinese (10.33 per 100,000) and Indians (9.34 per 100,000) than in Malays (6.62 per 100,000). The three commonest specific neuro-ophthalmic conditions were abducens nerve palsy (1.27 per 100,000), anterior ischemic optic neuropathy (1.08 per 100,000) and oculomotor nerve palsy (0.91 per 100,000). The incidence of optic neuritis was 0.83 per 100,000. Compared with the Singapore general population, the prevalence of diabetes was significantly higher in people aged 40-59, while the prevalence of hypercholesterolemia was significantly higher in 60-69 year age group.
CONCLUSION: In this study of public hospitals in Singapore, the incidence of neuro-ophthalmic diseases was higher in Chinese and Indians compared to Malays.

Entities:  

Mesh:

Year:  2009        PMID: 19353393     DOI: 10.1080/09286580902737516

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  7 in total

1.  A case of post-vaccination optic neuritis: coincidence or causative?

Authors:  S Sudarshan; E H Z Huang; P L Lim; Y S Leo; S A Lim
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

2.  Measurement of retinal nerve fiber layer thickness in optic atrophy eyes of patients with optic neuritis using optical coherence tomography.

Authors:  Xin-Ling Wang; Tao Yu; De-Zhao Xia; Jin-Song Zhang; Qi-chang Yan; Ya-Hong Luo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-27       Impact factor: 3.117

Review 3.  Update on Optic Neuritis: An International View.

Authors:  Simon J Hickman; Axel Petzold
Journal:  Neuroophthalmology       Date:  2021-08-31

4.  Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

Authors:  Steven Black; Juhani Eskola; Claire-Anne Siegrist; Neal Halsey; Noni MacDonald; Barbara Law; Elizabeth Miller; Nick Andrews; Julia Stowe; Daniel Salmon; Kirsten Vannice; Hector S Izurieta; Aysha Akhtar; Mike Gold; Gabriel Oselka; Patrick Zuber; Dina Pfeifer; Claudia Vellozzi
Journal:  Lancet       Date:  2009-10-31       Impact factor: 79.321

5.  Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.

Authors:  Manju Jayaraman; Rashmin Anilkumar Gandhi; Priya Ravi; Parveen Sen
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

6.  Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.

Authors:  E H Martínez-Lapiscina; E Fraga-Pumar; X Pastor; M Gómez; A Conesa; R Lozano-Rubí; B Sánchez-Dalmau; A Alonso; Pablo Villoslada
Journal:  J Neurol       Date:  2014-02-16       Impact factor: 4.849

Review 7.  Characterization of the Asian Phenotype - An Emerging Paradigm with Clinicopathological and Human Research Implications.

Authors:  Melvin Khee-Shing Leow
Journal:  Int J Med Sci       Date:  2017-06-15       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.